Globus Medical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Globus Medical şirketinin toplam hissedar öz sermayesi $4.1B ve toplam borcu $437.1M olup, bu da borç-öz sermaye oranını 10.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $5.1B ve $1.0B dir. Globus Medical 'in FAVÖK'ü $395.0M faiz karşılama oranı 52.1 dur. Şirketin $694.7M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

10.7%

Borç/özkaynak oranı

US$437.14m

Borç

Faiz karşılama oranı52.1x
NakitUS$694.71m
EşitlikUS$4.07b
Toplam yükümlülüklerUS$1.02b
Toplam varlıklarUS$5.09b

Son finansal sağlık güncellemeleri

Recent updates

Globus Medical Stock: Re-Rated After A Solid Year

Nov 18

Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Nov 04
Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Oct 14
Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Globus Medical: A Post Acquisition Analysis

Aug 26

Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Jun 28
Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: GMED 'nin kısa vadeli varlıkları ( $2.1B ) kısa vadeli yükümlülüklerini ( $818.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: GMED şirketinin kısa vadeli varlıkları ( $2.1B ) uzun vadeli yükümlülüklerini ( $198.6M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: GMED şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: GMED şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 10.7% seviyesine yükseldi.

Borç Kapsamı: GMED 'nin borcu işletme nakit akışı ( 94.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: GMED 'in borcuna ilişkin faiz ödemeleri EBIT ( 52.1 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin